www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

August 31, 2016

PDF Version

Supporting Materials:
FM_26_16UK_31082016.pdf

Copenhagen, 2016-08-31 14:26 CEST (GLOBE NEWSWIRE) --  

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions:
 

1.Details of the person discharging managerial responsibility / person closely associated
a)NameAndreas Slyngborg Holst
2.Reason for the notification
a)Position/statusMember of the Board of Directors (employee-elected)
b)
 
Initial notification/
amendment
Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameALK-Abelló A/S
b)LEI 
4.
 
Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the
financial instrument,
type of instrument 

Identification code
Share options

  
DK0060027142
b)
 
Nature of the transaction
 
Purchase (exercise of share options / purchase of shares – cash settlement)
The purchase price is based on the price at grant adjusted upwards annually by 2.5% less dividend payments.
c)
 
Price(s) and volume(s)
 
                     Price(s)                                   Volume(s)
                   420,741.75                                     975
d)Aggregated information
- Aggregated volume
- Price
 
975 
DKK 420,741.75
e)Date of the transaction2016-08-30
f)Place of the transactionNASDAQ Copenhagen

 

1.Details of the person discharging managerial responsibility / person closely associated
a)NameAndreas Slyngborg Holst
2.Reason for the notification
a)Position/statusMember of the Board of Directors (employee-elected)
b)Initial notification/
amendment
Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameALK-Abelló A/S
b)LEI 
4.
 
Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
 
Description of the
financial instrument,
type of instrument

Identification code
Share options
 
 
DK0060027142
b)
 
Nature of the transaction
 
Sale (exercise of share options/sale of shares – cash settlement)
The share options will be settled in cash and the final settlement is based on the average price of the Company's B shares quoted on NASDAQ Copenhagen A/S in a period of ten days.
c)
 
Price(s) and volume(s) 
 
                      Price(s)                                   Volume(s)
                     904,995                                       975
d)
 
Aggregated information
- Aggregated volume
- Price  
 
975
DKK 904,995
e)Date of the transaction2016-08-30
f)Place of the transactionNASDAQ Copenhagen

 
ALK-Abelló A/S
 

For further information please contact: 
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved